Reviva Pharmaceuticals Holdings Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Reviva Pharmaceuticals Holdings Inc 's ROA in the third quarter of 2026?
Reviva Pharmaceuticals Holdings Inc recorded a cumulative net loss of $-13 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -58.69%.

However, within the Healthcare sector 746 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 4302, from total ROA ranking in the first quarter of 2026 at 5171.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	191.59 %	232.9 %	2.71 %	87.85 %	44.48 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-13	-17	-20	-23	-27
Return On Assets (TTM)	-58.69 %	-101.62 %	-162.27 %	-187.5 %	-259.16 %
RVPH's Total Ranking	# 4302	# 5171	# 4622	# 4765	# 4865
Total Assets (TTM) in million	34	24	16	14	12
Seq. Total Assets Change	44 %	47.96 %	11.1 %	23.19 %	64.4 %
Seq. Net Income Change	-	-	-	-	-

RVPH's 5 Years Annual ROA >> Back to RVPH Management Effectiveness >> Compare RVPH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 346
Sector	# 747
Overall	# 4256

Return On Assets Statistics
High	Average	Low
-31.42 %	-188.24 %	-308.02 %
(Dec 31 2021)		(Sep 30 2023)

Financial Statements
Reviva Pharmaceuticals Holdings Inc 's Assets	$ 34 million	RVPH's Balance sheet
Reviva Pharmaceuticals Holdings Inc 's Income	$ -2 million	Quarterly RVPH's Income Statement
RVPH's Income by Division		See RVPH's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	2.71 %	-34.59 %	25.24 %	-39.74 %	-27.67 %
Total Assets in million	16	16	24	19	31
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-20	-30	-39	-24	-9
Annual Return On Assets	-124.75 %	-192.99 %	-165.65 %	-128.62 %	-27.14 %

RVPH's 5 Years Annual ROA >> Back to RVPH Management Effectiveness >> Compare RVPH ROA to its Competitors

More Return On Assets Ratios
RVPH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RVPH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for RVPH's Competitors
Subscribers only: Roa for Reviva Pharmaceuticals Holdings Inc 's Suppliers
Subscribers only: Return On Assets for RVPH's Customers

You may also want to know
RVPH's Roi	RVPH's Inventory Turnover Ratio	RVPH's Growth Rates	RVPH's Dividend Comparisons
	RVPH's Profitability Ratios	RVPH's Asset Turnover Ratio	RVPH's Dividend Growth
RVPH's Roe	RVPH's Valuation Ratios	RVPH's Financial Strength Ratios	RVPH's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector

ROA

Date modified: 2026-11-14T07:37:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.